2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $23K | $1.6M | $2.5M | $5.2M | $10T |
Cost of Revenue | $87K | $328K | $370K | $202K | $0 |
Gross Profit | -$64K | $1.3M | $2.1M | $5M | $10T |
Gross Profit % | -277% | 80% | 85% | 96% | 100% |
R&D Expenses | $6.6M | $590K | $301K | $182K | $16B |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$13M | -$8.5M | -$8.2M | -$7.8M | -$5.4T |
Dep. & Amort. | $0 | $0 | $0 | $0 | $0 |
Def. Tax | $0 | $0 | $0 | $0 | $0 |
Stock Comp. | $1.6M | $1.9M | $1.5M | $1.1M | $773K |
Chg. in WC | $4.9M | -$5.6M | $132K | $1.6M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $8.1M | $9.1M | $9.8M | $4.7M | $14M |
ST Investments | $0 | $0 | $0 | $0 | $14T |
Cash & ST Inv. | $8.1M | $9.1M | $9.8M | $4.7M | $14T |
Receivables | $23K | $295K | $625K | $673K | $2.4T |
Inventory | $236K | $186K | $289K | $482K | $445B |
EVOK reaffirmed its annual revenue growth guidance of 5% to 9% for 2025, despite expecting Q1 to be slightly below this range due to short-term impacts from new safer gambling measures, tough comps, and racing cancellations.
The company expects Q1 adjusted EBITDA to be £18–28 million higher year-over-year, with LTM EBITDA projected at £330–340 million by the end of Q1 2025, and aims for at least a 20% EBITDA margin for the full year.
Significant investments are being made in retail (including new gaming machines and store refurbishments), AI, and product development, resulting in increased CapEx (£100–110 million in 2025) and a revised leverage target of under 3.5x net debt/EBITDA by end of 2027.
EVOK reported strong H2 2024 results with 8% revenue growth and 29% adjusted EBITDA growth year-over-year, attributing sustainable growth to product innovation (e.g., BetBuilder, ImpactSub), improved customer lifecycle management, and a focus on core markets (UK, Italy, Spain, Romania, Denmark).
The company is seeing early positive results from its retail transformation, including market share gains in gaming, and expects sequential acceleration in NGR growth through Q2 and Q3; management remains confident in delivering profitable growth and material deleveraging, with a return to shareholder value creation as a key focus.